Skip to main content
. 2022 Apr 9;14(8):1902. doi: 10.3390/cancers14081902

Figure 3.

Figure 3

Contributions of major proteoglycans to HCC progression at cell level and their potential/current employment as molecular targets or therapeutic agents.